- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/56 - IFN-alpha
Patent holdings for IPC class C07K 14/56
Total number of patents in this class: 565
10-year publication summary
|
31
|
38
|
34
|
39
|
55
|
38
|
32
|
42
|
36
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vib VZW | 849 |
35 |
| Universiteit Gent | 1324 |
33 |
| Orionis Biosciences BV | 82 |
29 |
| Orionis Biosciences Inc. | 93 |
23 |
| Modernatx, Inc. | 1247 |
22 |
| Centre National de La Recherche Scientifique | 10165 |
20 |
| Centre hospitalier Regional universitaire de Montpellier | 30 |
15 |
| Teva Pharmaceuticals Australia Pty Ltd | 30 |
13 |
| CytomX Therapeutics, Inc. | 215 |
12 |
| IBC Pharmaceuticals, Inc. | 93 |
11 |
| Universite de Montpellier | 964 |
11 |
| ILC Therapeutics Ltd | 27 |
10 |
| Glaxo Group Limited | 4190 |
9 |
| Rutgers, The State University of New Jersey | 1864 |
9 |
| The Regents of the University of California | 19661 |
8 |
| Ubiprotein, Corp. | 11 |
8 |
| President and Fellows of Harvard College | 5898 |
6 |
| ImmunGene Inc. | 12 |
6 |
| Universitat Osnabruck | 11 |
6 |
| National Research Council of Canada | 1543 |
5 |
| Other owners | 274 |